• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

Schistosomiasis Control Initiative — General Support (2018)

Visit Grantee Site
  • Portfolio Area: GiveWell-Recommended Charities
  • Focus Area: Global Health & Development
  • Organization Name: Schistosomiasis Control Initiative
  • Amount: $2,500,000

  • Award Date: March 2018

Table of Contents

    A schoolchild in Cote d’Ivoire receives praziquantel treatment for schistosomiasis from a member of the drug distribution team. (Photo courtesy of the Schistosomiasis Control Initiative)

    The Open Philanthropy Project recommended a grant of $2,500,000 to the Schistosomiasis Control Initiative (SCI) via Imperial College Foundation for general support, due to its status as a GiveWell top charity. We followed the recommendation of GiveWell staff regarding how to allocate grantmaking between GiveWell top charities.

    Read GiveWell’s review of SCI to learn more about the charity’s activities and follow its progress.

    Related Items

    • GiveWell-Recommended Charities

      Schistosomiasis Control Initiative — General Support (2019)

      The Open Philanthropy Project recommended $2,500,000 to the Schistosomiasis Control Initiative (SCI) for general operating support, due to its status as a GiveWell top charity. We followed the...

      Read more
    • GiveWell-Recommended Charities

      Schistosomiasis Control Initiative — General Support (2017)

      Good Ventures awarded a grant of $13,500,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2017, in recognition of its earning a "top charity"...

      Read more
    • GiveWell-Recommended Charities

      Schistosomiasis Control Initiative — General Support (2016)

      Good Ventures awarded a grant of $1,000,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2016, in recognition of the organization's earning a "top...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!